Epidemiological characteristics of ischemic heart disease: A comparative study between China and the world from 1990 to 2021 and prediction to 2036

缺血性心脏病的流行病学特征:1990年至2021年中国与世界其他地区的比较研究及至2036年的预测

阅读:2

Abstract

BACKGROUND: Ischemic heart disease (IHD) is a major disease that endangers human health. There are relatively few comparative studies on the epidemiological characteristics of IHD. AIMS: This study aimed to compare and analyze the incidence, prevalence and mortality of IHD in China and the world from 1990 to 2021, predict its change trend from 2022 to 2036, and provide a basis for effective prevention and control of IHD. METHODS: Data on IHD in China and the world, encompassing age-standardized incidence rate (ASIR), age-standardized prevalence rate (ASPR), and age-standardized mortality rate (ASMR), was extracted from the Global Burden of Disease Study 2021. The Joinpoint regression model was employed to calculate the average annual percentage change (AAPC). The projected data for 2022-2036 were derived through calculations using the Bayesian age-period-cohort model. RESULTS: From 1990 to 2021, the growth rates of China's ASIR, ASPR, and ASMR of IHD were 15.97%, 20.42%, and 17.81% respectively, with annual percentage changes of 0.49%, 0.60%, and 0.49%, all higher than global levels; the annual change rates of incidence, prevalence, and mortality were 3.17%, 3.23%, and 3.54% respectively, also exceeding the world 1.00%, 1.38%, and 0.43%. In 1990, globally and in China, male incidence, prevalence, and mortality of IHD were generally higher than those of females, except that Chinese female mortality was lower; males had higher mortality but lower prevalence and related annual percentage changes, with the disease burden peaking in people aged 80 years and above. Over the next 15 years, the world and Chinese ASMR of IHD is projected to decline, while the male ASIR and ASPR will decrease, and those of females will increase. CONCLUSIONS: The burden of IHD and the increase rate in China was higher than global figures. Although ASMR for IHD in China and the world will decline over the next 15 years, IHD remains a public health issue that requires ongoing attention.To reduce the burden of IHD, targeted preventive measures and relevant knowledge popularization should be adopted for populations of different genders and ages.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。